Hosted By
Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Useful Links
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Chronic Fatigue Quiz: https://app.annamarsh.co.uk/quiz-page
Instagram: https://www.instagram.com/anna__marsh_
Work with me: https://annamarsh.co.uk/work-together/
Website: http://annamarsh.co.uk/
Join the Nurturing Resilience Subscription: https://annamarsh.co.uk/nurturing-resilience/
Contrary to what many people think about Chronic Fatigue Recovery, we are not supposed to be calm all the time. Rest matters and we...
Shownotes The cell danger response (CDR) is the body’s universal and ancient response to threat. It offers a framework from which we can begin...
Shownotes In this episode Anna digs deeper into brain injuries and neuroinflammation. If you are someone experiencing chronic fatigue, your support plan should consider...
